When was Konexio Biotech founded?

Konexio Biotech was founded in 2023.

Where is Konexio Biotech located?

Konexio Biotech is headquartered in Madrid, Spain.

Who is the current CEO of Konexio Biotech?

Andrea Romero Lopez of Konexio Biotech. They have also founded 1 company.

How many employees does Konexio Biotech have?

As of Apr 30, 2026, the latest employee count at Konexio Biotech is 14.

Is Konexio Biotech a funded company?

Konexio Biotech is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Konexio Biotech rank among its competitors?

Konexio Biotech ranks 580th amongst 1345 active competitors, of which 26 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of Konexio Biotech?

Konexio Biotech's top competitors include Indegene, IntegriChain and Prescient Healthcare Group. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

Konexio Biotech - 2026 Company Profile, Team & Competitors

Konexio Biotech is an unfunded company based in Madrid (Spain), founded in 2023 by Andrea Romero Lopez. It operates as a Biotechnology consulting firm providing services to clients in the pharmaceutical and cosmetic industries. Konexio Biotech has not raised any funding yet. The company has 1345 active competitors, including 26 funded and 147 that have exited. Its top competitors include companies like Indegene, IntegriChain and Prescient Healthcare Group.

Company Details

Website: konexiobiotech.com
Social
Email ID: *****@konexiobiotech.com
Phone Number: +34 **********

Key Metrics

Founded Year

2023

Location

Madrid, Spain

Stage

Unfunded

Ranked

580^th among 1345 active competitors

Employee Count

14 as on Apr 30, 2026

Similar Companies

Indegene & 1604 more

View Konexio Biotech's full profile

Konexio Biotech has not raised any funding rounds yet.

The founders of Konexio Biotech is Andrea Romero Lopez. Andrea Romero Lopez is the CEO of Konexio Biotech.

Here are the details of Konexio Biotech's key team members:

Andrea Romero Lopez: Co-Founder & CEO of Konexio Biotech.

View details of Konexio Biotech's Founder profiles and Board Members

Konexio Biotech's employee count trend

Konexio Biotech has 14 employees as of Apr 26. Here is Konexio Biotech's employee count trend over the years:

Employee count trend for Konexio Biotech

Uncover Konexio Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Konexio Biotech include Indegene, IntegriChain and Prescient Healthcare Group. Here is the list of Top 10 competitors of Konexio Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Syneos Health, Cadawninvestmentcompany & 17 others	78/100
2nd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	63/100
3rd	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Bridgepoint Group, Baird Capital & 8 others	60/100
4th	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
5th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
6th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
7th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	56/100
8th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
9th	Science Group 1986, Cambridge (United Kingdom), Public	Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors	-	Herald Investment Management	49/100
10th	Spectrum Pharmatech Consultants 1995, Thane (India), Unfunded	Provider of diversified consulting services for biopharma sector	-	-	49/100
580th	Konexio Biotech 2023, Madrid (Spain), Unfunded	Biotechnology consulting firm providing services to clients in the pharmaceutical and cosmetic industries	-	-	20/100